| Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937) |
|---|
| 06/07/2001 | WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 06/07/2001 | CA2391096A1 3-methylene steroid derivatives |
| 06/05/2001 | US6242619 19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function |
| 06/05/2001 | CA2065861C Process for the manufacture of budesonide |
| 05/02/2001 | EP1094798A2 INHIBITORS OF TYPE 5 AND TYPE 3 17beta-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 04/25/2001 | EP1093816A2 Use of ST1435 in hormonal therapy by transdermal application |
| 04/05/2001 | WO2001022959A2 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| 04/05/2001 | CA2657208A1 Method of treating inflammatory conditions with progesterone of progesterone analogs |
| 03/27/2001 | USRE37116 Nitrosated and nitrosylated compounds, and compositions and their use for treating respiratory disorders |
| 03/06/2001 | US6197762 Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders |
| 02/28/2001 | CN1285750A New composition of matter |
| 02/28/2001 | CN1062562C Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 02/27/2001 | US6194565 Antiinflammatory agent |
| 02/27/2001 | CA2081205C Steroids which inhibit angiogenesis |
| 02/22/2001 | WO1999046279A3 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 02/20/2001 | CA2083404C Therapeutically effective topical application of st1435 |
| 02/14/2001 | CN1061984C Introduction method of 9-11 double bond into steroid hormone compound |
| 02/07/2001 | EP1074558A1 Process for the preparation of mometasone furoate |
| 02/07/2001 | CN1282744A Preparation of furoic acid momisone |
| 01/30/2001 | US6180803 Steroid drugs |
| 01/24/2001 | CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 01/23/2001 | US6177560 Direct esterification of the 17 hydroxyl group without prior protection of the free 11 hydroxy function. |
| 01/17/2001 | EP0808325B1 Androstane and pregnane series for allosteric modulation of gaba receptor |
| 01/16/2001 | CA2140345C Anti-inflammatory compounds for ophthalmic use |
| 01/09/2001 | US6172052 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 12/20/2000 | EP1059977A2 Recovery of organic solutes from aqueous solutions |
| 12/19/2000 | CA2014759C Novel steroid derivatives |
| 12/05/2000 | CA2027627C Process for preparing 21-desoxyprednisolone 17-esters |
| 11/22/2000 | CN1058724C Use of steroid compound for preparing medicaments |
| 11/07/2000 | US6143736 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 10/26/2000 | WO2000063229A1 Steroid derivatives |
| 10/26/2000 | WO2000062735A2 Treatment of neoplasms with viruses |
| 10/11/2000 | CN1057304C 17,20-epoxide derivatives of pregnance, their preparation, their use in preparation of cortisome derivatives and intermediates |
| 10/11/2000 | CN1057303C Preparation process for 16 beta-methyl steroid and new intermediates thereof |
| 10/05/2000 | WO2000029088A3 Recovery of organic solutes from aqueous solutions |
| 10/04/2000 | EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 09/27/2000 | EP1038880A2 Androstanes and pregnanes for allosteric modulation of GABA receptor |
| 09/20/2000 | EP1036088A1 Method of preparing 16 alpha,17 alpha-dialkylated steroids |
| 09/14/2000 | WO2000053619A1 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
| 09/14/2000 | CA2359218A1 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
| 09/12/2000 | US6117994 Intermediates for 16β-methyl steroids |
| 09/06/2000 | EP1032396A1 New composition of matter |
| 09/06/2000 | CN1056151C 17-deoxycorticosteroid-21-(O)-carboxylic esters, process for their preparation and pharmaceuticals containing these compounds |
| 08/23/2000 | EP0752860B1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 07/05/2000 | EP0900234B1 21-substituted progesterone derivatives as new antiprogestational agents |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |
| 07/05/2000 | CN1054133C 17-spiromethylene steroids |
| 06/15/2000 | WO2000034306A1 17β-ACYL-17α-PROPYNYL-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES |
| 06/14/2000 | EP1007017A1 New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 06/06/2000 | US6071410 Dry, non-conditioned sorbent medium comprising a blend of a polymethacrylate resin and a polystyrene resin. |
| 05/31/2000 | EP1003553A1 The use of angiostatic steroids in photodynamic therapy |
| 05/25/2000 | WO2000029088A2 Recovery of organic solutes from aqueous solutions |
| 05/25/2000 | DE19848305C1 Conversion of propargyl alcohol derivatives to alpha,beta-unsaturated ketone or alkyne derivatives comprises reaction with an acidic cation-exchange resin in an organic solvent |
| 05/24/2000 | CN1254283A Pregnan-3-ol-20-ones |
| 05/24/2000 | CN1052729C Steroids containing in position 20 aminosubstituted chain, their preparation process and use, and pharmaceutical compositions containing them |
| 05/17/2000 | CN1052489C Process for preparation of 16 alpha-methyl steroids |
| 05/10/2000 | EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life |
| 05/10/2000 | EP0494224B1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 05/10/2000 | CN1052155C Process for preparing pharmaceutical composition containing new steriod compounds |
| 04/27/2000 | WO2000023460A1 HIGH PURITY COMPOSITION COMPRISING (7α,17α)- 17-HYDROXY- 7-METHYL- 19-NOR-17-PREGN- 5(10)-EN-20-YN-3-ONE |
| 04/25/2000 | CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids |
| 04/20/2000 | WO2000021977A1 Pregnane glucuronides |
| 04/20/2000 | CA2346693A1 Pregnane glucuronides |
| 04/12/2000 | EP0992512A2 Reduced cortisol conjugate |
| 04/12/2000 | CN1051316C Cortinoid derivative, its producing process and medicine containing the same |
| 03/29/2000 | EP0988057A1 Drug targeting |
| 03/22/2000 | CN1248162A Topical pharmaceutical composition comprising cholinergic agent or calcium channel blocker |
| 03/21/2000 | US6040468 Method of preparing 16α, 17α-dialkylated steroids |
| 03/15/2000 | EP0533703B1 Use of steroids for the inhibition of angiogenesis |
| 03/01/2000 | EP0981349A1 Pregnan-3-ol-20-ones |
| 02/29/2000 | US6030604 Formulation for inhalation |
| 02/23/2000 | EP0898579B1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 02/15/2000 | CA2082284C Process for the preparation of 20-oxo 17.alpha.,21-dihydroxylated derivatives of pregnane and new intermediate compounds |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 02/02/2000 | CN1243436A New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
| 01/18/2000 | US6015821 Skin, psychological and cardiovascular disorders; anticarcinogenic, antiinflammatory and antidiabetic agents |
| 01/12/2000 | EP0969813A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 01/05/2000 | EP0969012A2 Process for preparing delta 9,11 and 21-chloro corticosteroids |
| 01/05/2000 | EP0969011A2 Process for preparing delta 9,11 and 21-chloro corticosteroids |
| 01/05/2000 | EP0763054B1 Process for preparing delta 9,11 and 21-chloro corticosteroids |
| 01/04/2000 | US6011023 Angiostatic steroids |
| 11/30/1999 | US5994333 Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 11/23/1999 | US5990099 Treating glc1a glaucoma by administering an angiostatic steroid of given formula |
| 10/26/1999 | US5972922 Steroids which inhibit angiogenesis |
| 09/29/1999 | EP0593520B1 Ocular compositions containing steroids and their use in treating glaucoma |
| 09/16/1999 | WO1999046279A2 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 09/16/1999 | CA2323089A1 Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use |
| 09/15/1999 | EP0941361A1 A method for the preparation of steroid compounds |
| 09/14/1999 | US5952499 Therapeutic compound-fatty acid conjugates |
| 09/01/1999 | EP0886645B1 New 19-nor-pregnene derivatives |
| 08/31/1999 | US5945530 17,20-epoxy steroid intermediates |
| 08/17/1999 | US5939545 Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 08/17/1999 | US5939409 Processes for the production of anti-inflammatory steroids |
| 08/04/1999 | CN1225098A 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| 07/21/1999 | EP0565553B1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES |
| 07/20/1999 | US5925630 Neuroactive steroids of the androstane and pregnane series |
| 07/07/1999 | CN1222160A Pregnane derivatives with no alpha-17 substitutent, their medicinal use, mfg. method and its intermediaries and related compounds |
| 07/06/1999 | US5919957 For the preparation of oxoetiocholenic acid |
| 07/01/1999 | WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension |